- Bernard P, Antonicelli F. Bullous pemphigoid: a review of its diagnosis, associations and treatment. Am J Clin Dermatol. 2017;18(4):513–528. doi: 10.1007/s40257-017-0264-2.
- Ahmed A, Shetty S, Kaveri S, Spigelman Z. Treatment of recalcitrant bullous pemphigoid (BP) with a novel protocol: a retrospective study with a 6-year follow-up. J Am Acad Dermatol. 2016;74(4):700–708. doi: 10.1016/j.jaad.2015.11.030.
- Amagai M, Ikeda S, Hashimoto T, et al. A randomized double-blind trial of intravenous immunoglobulin for bullous pemphigoid. J Dermatol Sci. 2016; 85(2):77–84. doi: 10.1016/j.jdermsci.2016.11.003.
- Lamberts A, Euverman H, Terra J, Jonkman MF, Horváth B. Effectiveness and safety of rituximab in recalcitrant pemphigoid diseases. J Invest Dermatol. 2018;138(5 Suppl):S71. doi: 10.1016/j.jid.2018.03.423.
- Uchida S, Oiso N, Koga H, Ishii N, Okahashi K, Matsuda H, Hashimoto T, Kawada A. Refractory bullous pemphigoid leaving numerous milia during recovery. J Dermatol. 2014;41(11):1003–1005. doi: 10.1111/1346-8138.12650.
- Prost C, Labeille B, Chaussade V, Guillaume JC, Martin N, Dubertret L. Immunoelectron microscopy in subepidermal autoimmune bullous diseases: a prospective study of IgG and C3 bound in vivo in 32 patients. J Invest Dermatol. 1987;89(6):567–573. doi: 10.1111/1523-1747.ep12461226.
- Tsuruta D, Brzezinski P, Koga H, Ohata C, Furumura M, Hashimoto T. Bullous pemphigoid with prominent milium formation. Acta Dermatovenerol Croat. 2013; 21(1):35–38.
- Venning VA, Whitehead PH, Leigh IM, Allen J, Wojnarowska F. The clinical expression of bullous pemphigoid is not determined by the specificity of the target antigen. Br J Dermatol. 1991;125(6):561–565.
- Banfield CC, Wojnarowska F, Allen J, George S, Venning VA, Welsh KI. The association of HLA-DQ7 with bullous pemphigoid is restricted to men. Br J Dermatol. 1998;138(6):1085–1090.
- Hisa T, Goto Y, Taniguchi S, Nakanishi T, Kakudo K, Takigawa M. Post-bullous milia. Australas J Dermatol. 1996;37(3):153–154.
- Ding S, Deng Q, Xiang Y, Chen J, Huang J, Lu J. Bullous pemphigoid associated with milia, increased serum IgE autoantibodies against desmogleins, and refractory treatment in a young patient. An Bras Dermatol. 2017;92(5):34–36. doi: 10.1590/abd1806-4841.20176124.
Milia within resolving bullous pemphigoid lesions
Reprints and Corporate Permissions
Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?
To request a reprint or corporate permissions for this article, please click on the relevant link below:
Academic Permissions
Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?
Obtain permissions instantly via Rightslink by clicking on the button below:
If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.